书签 分享 收藏 举报 版权申诉 / 4
1

类型[20181107]IN10991_加拿大大麻合法化:对美国政策和国际药物管制的影响.pdf

  • 上传人:任**
  • 文档编号:27662
  • 上传时间:2022-06-24
  • 发布时间:2018-11-07
  • 格式:PDF
  • 页数:4
  • 大小:595.07KB
  • CRS INSIGHT Prepared for Members and Committees of Congress INSIGHTINSIGHTi i Marijuana Legalization in Canada: Implications for U.S. Policy and International Drug Control Peter J. Meyer Specialist in Latin American Affairs Liana W. Rosen Specialist in International Crime and Narcotics Lisa N. Sacco Analyst in Illicit Drugs and Crime Policy Updated November 7, 2018 On October 17, 2018, Canada became the second countryafter Uruguay in 2013to legalize and regulate the production, distribution, and possession of marijuana for recreational purposes. The measure comes at a time when other countries are questioning their drug policies and U.S. states are forging policy paths that diverge from federal law. These developments have spurred questions from Congress regarding their potential implications for U.S. domestic and international drug policy. Canadas Cannabis Act Canadas Cannabis Act allows individuals 18 years of age or older to purchase marijuana from authorized sellers, grow up to four plants in their homes, and possess up to 30 grams (a little over an ounce) of dried marijuana. The federal government is responsible for regulating production, while each of Canadas 13 provincial an
    展开阅读全文
    特殊限制:

    部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。

    关 键  词:
    20181107 IN10991_ 加拿大 大麻 合法化 美国 政策 国际 药物 管制 影响
    1
    提示  联参智库所有资源均是用户自行上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作他用。
    关于本文
    本文标题:[20181107]IN10991_加拿大大麻合法化:对美国政策和国际药物管制的影响.pdf
    链接地址:https://www.lianhezuozhan.com/doc/27662.html
    1

    客服:010-66465788   北京联参科技有限公司版权所有  工业和信息化部备案/许可证编号:京ICP备2022007273号-1



    联参智库